» Articles » PMID: 37456973

Adult Eosinophilic Esophagitis and Advances in Its Treatment

Overview
Specialty General Medicine
Date 2023 Jul 17
PMID 37456973
Authors
Affiliations
Soon will be listed here.
Abstract

Eosinophilic esophagitis (EoE) is a chronic eosinophil inflammation that seems to be T helper type 2 antigen-driven. The disease is one of several eosinophilic gastrointestinal disorders in which there appears to be inflammation of the gastrointestinal tract without any apparent underlying causes. Differential diagnosis needs to be made with gastroesophageal reflux, which is characterized by chronic inflammation due to gastric refluxate from disorders related to motility. EoE, however, is considered a chronic allergic inflammatory disorder related to destructive tissue remodeling. There seems to be a higher prevalence of EoE in Western countries. It is typically found in atopic male individuals. Physiopathological risk factors include atopy, environmental factors, esophageal epithelial barrier dysfunctions, EoE can cause several symptoms that include retrosternal burning sensation, dysphagia, food impaction, chronic reflux symptoms, nausea, and vomiting. Early diagnosis, which requires a biopsy to assess for esophageal inflammation, is essential for proper treatment. The aim of our brief overview is to summarize the current literature regarding the characteristics, diagnosis, complications, mechanisms of pathology, clinical features, influence of comorbidities, and treatment in patients with EoE.

References
1.
Davis B . Pathophysiology of Eosinophilic Esophagitis. Clin Rev Allergy Immunol. 2018; 55(1):19-42. DOI: 10.1007/s12016-017-8665-9. View

2.
Winter H, Madara J, Stafford R, Grand R, Quinlan J, Goldman H . Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982; 83(4):818-23. View

3.
Wolf W, Jerath M, Sperry S, Shaheen N, Dellon E . Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014; 12(8):1272-9. PMC: 4102669. DOI: 10.1016/j.cgh.2013.12.034. View

4.
Cheng E, Zhang X, Huo X, Yu C, Zhang Q, Wang D . Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2012; 62(6):824-32. PMC: 3552049. DOI: 10.1136/gutjnl-2012-302250. View

5.
Straumann A, Aceves S, Blanchard C, Collins M, Furuta G, Hirano I . Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy. 2012; 67(4):477-90. DOI: 10.1111/j.1398-9995.2012.02787.x. View